Tag: license

TORONTO, Ontario and HAIFA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce today that its wholly owned U.S. subsidiary, Exo-Top Inc. (“Exo-Top”), has entered into a binding memorandum of understanding (the “MOU”) setting out the principal commercial terms for a proposed definitive distribution agreement (the “Definitive Agreement”) with ExoLyra LLC, which operates as an arm’s length third party (“ExoLyra”).

DENVER, June 24, 2026 (GLOBE NEWSWIRE) -- Recently, SKHTU Exchange formally submitted its license application materials to the Monetary Authority of Singapore (MAS), marking the entry of the platforms compliance deployment in the Asian market into a substantive review phase. It is understood that the relevant application materials have completed preliminary acceptance, and the subsequent process will proceed to the document review and operational assessment stage in accordance with the regulatory procedures.

DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- Recently, regulatory oversight of digital assets in Europe has continued to intensify. SKHTU Exchange has formally submitted its license application materials to the UK Financial Conduct Authority (FCA) and maintains close communication with the regulatory body during the approval process.

Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) acquired two 1,500 MHz frequency blocks for almost EUR 10 million and stood out as the largest investor in the 1,500 MHz frequency band in an auction organized by the Communications Regulatory Authority (CRA). The Company received the largest share of these frequencies sold – 40 MHz, which will be used for further development of the 5G network. Along with this achievement, Telia Lietuva also extended the right to use the 2,100 MHz frequency band in another auction, committing to pay the state another EUR 2 million for this right.